Is Brimonidine in shortage in 2026? Get the latest update on Brimonidine availability, why it's hard to find, current costs, and how to get your prescription filled.
If you use Brimonidine eye drops to manage glaucoma or ocular hypertension, you may have heard rumors about shortages — or experienced the frustration of a pharmacist telling you they're out. In this update, we'll give you the real picture of Brimonidine availability in 2026 and practical steps you can take to keep your treatment on track.
As of early 2026, Brimonidine is not listed on the FDA's official drug shortage database. That means there is no confirmed, widespread national shortage of this medication.
However, that doesn't mean you'll always find it at your local pharmacy. Individual pharmacies may experience temporary stock-outs due to:
The important distinction is that Brimonidine is being manufactured and distributed normally — the issue is typically at the individual pharmacy level, not a nationwide supply problem.
Even without an official shortage, several factors can make it feel like Brimonidine is hard to get:
Brimonidine comes in several formulations — 0.1%, 0.15%, and 0.2% ophthalmic solutions. A pharmacy might have the 0.2% generic in stock but not the 0.15% Alphagan P your doctor prescribed. This version mismatch is one of the most common reasons patients are told their medication "isn't available."
Eye drops require sterile manufacturing environments, which makes production more complex (and more vulnerable to delays) compared to tablets or capsules. When a generic manufacturer has a quality issue at their sterile facility, it can temporarily reduce supply of multiple ophthalmic products, including Brimonidine.
Chain pharmacies use algorithms to decide what to keep on shelves. If your location doesn't fill many Brimonidine prescriptions, it might not be part of their regular inventory. This is especially common at pharmacies in areas with younger populations where glaucoma is less prevalent.
For a more detailed breakdown, read our guide on why Brimonidine is so hard to find.
Cost is a real factor in whether patients can access their medication. Here's what you can expect to pay:
If cost is a barrier for you, there are savings programs available. AbbVie offers a co-pay assistance program for Alphagan P worth up to $2,160 per year, and the Allergan Patient Assistance Program provides the medication at no cost to eligible uninsured patients. Learn more in our complete guide on how to save money on Brimonidine.
The glaucoma treatment landscape continues to evolve. While Brimonidine remains a staple, patients and doctors now have additional options:
Talk to your ophthalmologist about whether any of these newer approaches might be right for you.
If you need Brimonidine today, here's your action plan:
For detailed tips, see our guide on how to find Brimonidine in stock near you.
The bottom line: Brimonidine is not in a national shortage in 2026, but real-world availability can still be spotty depending on where you live and which pharmacy you use. The solution is usually straightforward — check stock online, try a different pharmacy, or ask your pharmacist to order it.
What you should never do is skip your glaucoma medication. Untreated eye pressure causes permanent, irreversible vision loss. If you're having trouble finding Brimonidine, reach out to your eye care team for help.
Stay informed with these related guides:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
